• Vaccines

Abrysvo Generic Name & Formulations

General Description

Respiratory syncytial virus vaccine; soln for IM inj after reconstitution; preservative-free.

Pharmacological Class

RSV vaccine.

How Supplied

Kits—1, 5, 10 (w. supplies)


Generic Availability


Mechanism of Action

Abrysvo induces an immune response against RSV pre F that protects against lower respiratory tract disease caused by RSV.

Abrysvo Indications


Active immunization of pregnant individuals at 32 through 36 weeks gestational age for the prevention of lower respiratory tract disease (LRTD) and severe LRTD caused by respiratory syncytial virus (RSV) in infants from birth through 6 months of age. Active immunization for the prevention of LRTD caused by RSV in adults aged ≥60yrs.

Abrysvo Dosage and Administration


Pregnant individuals (32–36 weeks gestational age) or Adults (≥60yrs): one single dose (0.5mL) by IM inj.


<18yrs: not established.

Abrysvo Contraindications

Not Applicable

Abrysvo Boxed Warnings

Not Applicable

Abrysvo Warnings/Precautions


Potential risk for preterm birth; use only as indicated. Have appropriate medical treatment available. Syncope. Immunocompromised. Vaccination may not protect all recipients. Pregnancy. Nursing mothers. 

Abrysvo Pharmacokinetics

See Literature

Abrysvo Interactions


Concomitant immunosuppressants: may get suboptimal response.

Abrysvo Adverse Reactions

Adverse Reactions

Fatigue, headache, inj site pain, muscle pain; anaphylaxis. 

Abrysvo Clinical Trials

See Literature

Abrysvo Note

Not Applicable

Abrysvo Patient Counseling

See Literature